Many of our practices could be more efficient at checking in patients, or perhaps more precise in our record keeping. Insurance claims denials and the process of fighting them can be one source of time-consuming, money-draining aggravation for any practice. But we may be seeing a trend toward technologies that could ease these clerical and financial burdens. To learn a little more about the digital developments that are helping us validate patients' insurance eligibility in advance of their medical visit, host Dr. Larry Kaskel welcomes Nick Galantino, chief executive officer of the LoCicero Medical Group, a nine-provider internal medicine practice in Tampa, Florida, which uses one of the devices currently on the market.
Digital Developments to Help Validate Insurance at Check-In

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Many of our practices could be more efficient at checking in patients, or perhaps more precise in our record keeping. Insurance claims denials and the process of fighting them can be one source of time-consuming, money-draining aggravation for any practice. But we may be seeing a trend toward technologies that could ease these clerical and financial burdens. To learn a little more about the digital developments that are helping us validate patients' insurance eligibility in advance of their medical visit, host Dr. Larry Kaskel welcomes Nick Galantino, chief executive officer of the LoCicero Medical Group, a nine-provider internal medicine practice in Tampa, Florida, which uses one of the devices currently on the market.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Love Story: Lipid Education for Women’s Heart Health
Level Up Your Skills: Tailoring Management of HF
Personalizing Care Within the RCC Treatment Paradigm
Navigating Myasthenia Gravis in Adolescents and Young Adults
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?